D-Phenylalanine and Other Enkephalinase Inhibitors as Pharmacological Agents: Implications for Some Important Therapeutic Application

Abstract

A number of compounds have been shown to inhibit the degradation of enkephalins. As expected, these compounds produce naloxone reversible analgesia and potentiate the analgesia produced by enkephalins and by acupuncture. One of these, D-phenylalanine, is also anti-infiammatory. D-phenylalanine has proven to be beneficial in many human patients with chronic, intractable pain. It is proposed the enkephalinase inhibitors may be effective in a number of human “endorphin deficiency diseases” such as depression, schizophrenia, convulsive disorders and arthritis. Such compounds may alleviate other conditions associated with decreased endorphin levels such as opiate withdrawal symptoms.

Keywords

D-phenylalanine enkephalinase inhibitors endorphins endorphin deficiency disease anti-inflammatory agent analgesia arthritis depression schizophrenia enkephalins

Get full access to this article

View all access options for this article.

References

Goldstein

Tachibana

Lowney

L.I.

Hunkapiller, and Hood, L. “Dynorphin-(1-13), an extraordinarily potent opioid peptide”. Proc. Ntl. Acad, of Sci. 76 (12) 6666–6670, Dec., 1979.

Wei

and Loh

H.H

. Science 193: 1261–1263, 1976.

Wei

E.T

. “Enkephalin analogs and physical dependence”. J. Pharmac. Exp. Ther. 216: 12–18, 1981.

Ehrenpreis

Comaty

J.E.

and Myles

S.B

. “Naloxone reversible analgesia produced by D-phenylalanine in mice” in Characteristics and Function of Opioids, Van Ree and Terenius (eds.), pp. 417–418, 1978.

Hughes

“Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine”. Brain Res. 88: 295–308, 1975.

Ehrenpreis

Balagot

R.C.

Comaty

J.E.

and Myles

S.B

. “Naloxone reversible analgesia in mice produced by D-phenylalanine and hydrocinnamic acid, inhibitors of carboxypeptidase A”. Adv. in Pain Res. and Ther. 3:479–487, 1979.

Cheng, Richard S.S. and Pomeranz, B. “Correlation of genetic differ-ences in endorphin systems with analgesic effects of D-amino acids in mice”. Brain Res. 177: 583–587, 1979-

Cheng

R.S.

and Pomeranz

“A combined treatment with D-amino acids and electroacupuncture produces a greater analgesia than either treatment alone; naloxone reverses these effects”. Pain 8: 231–236, 1980.

Alleva

Castellano

and Oliverio

“Effects of L- and D- amino acids on analgesia and locomotor activity of mice: their interaction with morphine. Brain Res. 198: 249–252, 1980.

10.

Ehrenpreis

Balagot

R.C.

Mosnaim

A.O.

Szanto

Myles

Hyodo

Okafor

Ellyin

F.E.

and Singh

S.P

. “Acute and chronic toxicity of D-phenylalanine (DPA) in animals and humans”. Abstracts, First World Congress on Toxicology and Environmental Health, Am. Coll. Toxicology, Washing-ton, D.C., Hay 1982, p. 23.

11.

Miller

R.J

. Chang

K.-J.

and Cuatrecasas

“The metabolic stability of the enkephalins”., Biochem and Biophys. Res. Comm. 74 (4) 1311–1317. 1977.

12.

Patthy

Graf

Kenessey

Szekely

, and Bajusz

“Effect of bacitracin on the biodegradation of B-endorphin”. Biochem. and Biophys. Res. Comm. 79 (1) 254–259, 1977.

13.

Knight

and Klee

W.A

. “The relationship between enkephalin degra-dation and opiate receptor occupancy”. J. Bio. Chern. 253 (11) 3843–3847, 1978.

14.

Vogel

and Altstein

“The effect of puromycin on the biological activity of leu-enkephalin”. FEBS Letters 98 (1) 44–48, 1979.

15.

Ehrenpreis

Greenberg

Kubota

and Myles

S.B

. in “Advances in Endogenous and Exogenous Opioids”, H. Takagi and E.J. Simon (eds.), Kodansha-Elsevier, Tokyo, Japan, 1982 in press.

16.

Simmons

W.H.

and Ritzmann

R.F

. “An inhibitor of opioid peptide degradation procduces analgesia in mice”. Pharmac. Biochem. S Behavior 13-’ 715-718, 1980.

17.

Roques

B.P.

Fournier-Zaluski

M.C.

Soroca

Lecomte

J.H.

Malfroy

Llorens

, and Schwartz

J.-C

. “The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice”. Nature 288: 286–289, 1980.

18.

Lewis

R.V.

Stern

Kimura

Stein

and Undenfriend

“Enkephalin biosynthetic pathways: proteins of 8000 and 14,000 daltons in bovine adrenal medulla”. Proc. Natl. Acad. Sci., 77 (8) 5018–5020, 1980.

19.

Rossier

Trifaro

J.M.

Lewis

R.V.

Lee

R.W.H.

Stern

Kumara

Stein

and Udenfriend

“Studies with (35s)methionine indicates that the 22,000-dalton (met)enkephalin-containing protein in chromaffin cells is a precursor of (met)enkephalin”. Proc. Natl. Acad. Sci. 77 (11) 6889–6891, 1980.

20.

Mizuno

Minamino

Kangawa

and Matsuo

in “Advances in Endogenous and Exogenous Opioids”, H. Takagi and E.J. Simon (eds.), Kodansha- Elsevier, Tokyo, 1982 in press.

21.

S. Ehrenpreis

R.C.

Balagot

S.B.

Myles, C. Advocate and J.E. Comaty in “Endogenous and Exogenous Opiate Agonists and Antagonists”, E. Leong Way (ed.), Pergamon Press, 379–381, 1980.

22.

Balagot

R.C.

and Ehrenpreis

“Continuing Studies of D-phenylalanine induced analgesia in mice and humans”. Anesthesiology 51:S231, 1979.

23.

Balagot

R.C.

Ehrenpreis

Kubota

and Greenberg

“Analgesia in mice and humans by d-phenylalanine: relation to inhibition of enkephalin degradation and enkephalin levels”. Pain S21(SI), 1981.

24.

Budd

“The use of d-phenylalanine, an enkephalinase inhibitor, in the treatment of intractable pain”. Pain S95(S1), 1981.

25.

Bella

Carenzi

Frigeni

and Santini

“Effect of Carboxy-peptidase inhibition on the in vivo and in vitro pharmacological properties of morphine and enkephalins”. Neuropharm. 18: 719–721, 1979.

26.

Greenberg

Kubota

Ehrenprels

and Hetnarskl

“Analgesic properties of D-phenylalanine (DPA), bacitracin and puromycin, Inhibitors of en-kephalinase. Abst. 8th. Int. Cong. Pharm., Tokyo, Japan, August, 1981, p. 281.

27.

Carenzi

Morpugo

Bella

“Strong analgesic activity of leu- enkephalin after inhibition of brain aminopeptidase: pharmacological and bio-chemical studies”. In Advances in Endogenous and Exogensous Opioids”, H. Takagi and E.J. Simon (eds.), Kodansha-Eisevier, Tokyo, 1982 in press.

28.

Stine

S.M.

Tang

H.-Y.

and Costa

“Inhibition of in situ metabolism of (3H) (metS)-enkephalin and potentiation of (met5)-enkephalin analgesia by captopril”. Brain Res. 188: 295–299, 1980.

29.

Dua

A.K.

LaBella

F.S.

, and Pinsky

“Peptidase inhibitors re-duce opiate withdrawal severity and may diminish epileptogensis in rats”. Fed. Proc. 39: 386 (615), 1980.

30.

Clement-Jones

Tomlin

Rees

McLoughlin

Besser

and Wein

H.L

. “Increased B-endorphin but not met-enkephalin levels in human cerebrospinal fluid after acupuncture for recurrent pain”. Lancet 2 (8201) 946- 949. 1980.

31.

Lai

S.S

. “Beta-endorphin and electroacupuncture”. Lancet 2 (8207) 1309, 1980.

32.

Abbate

and Santamaria

“Beta-endorphin and electroacupuncture”. Adv. Biochem. Psychopharm. 22: 237–246, 1980.

33.

Akil

Richardson

D.E.

Barchas

J.D.

and Li

C.H

. “Appearance of B-endorphin-like immunoreactivity in human ventricular cerebrospinal fluid upon analgesic electrical stimulation”. Proc. Natl. Acad. Sci. 75 (10) 5170–5172, 1978.

34.

Nakano

and Ikezono

“Effects of electroacupuncture in the levels of endorphins and substance P in human lumbar CSP”, in Advances in Endogenous and Exogenous Opioids”, H. Takagi and E.J. Simon (eds.), Kodansha-Elsevier, Tokyo, 1982 in press.

35.

Jisheny

Yuanzhen

Kian

and Zhengfu

“Augumentation of acupuncture analgesia by peptidase inhibitor D-phenylalanine in rabbits. Acta Zoo. Sinica. 27:133–138, 1981.

36.

Hyodo

“A study on the enchanced analgesic effect induced by pheyla- lanine during acupuncture analgesia in human beings”. Pain S181(SI), 1981.

37.

Takeshige

Murai

and Tanaka

“Parallel individual variation in effectiveness of acupuncture, morphine analgesia and dorsal PAG-SPA and its abolishment by d-phenylalanine”, in Advances in Endogenous and Exogenous Opioids”, H. Takagi and E.J. Simon (eds.), Kodansha-Elsevier, Tokyo, 1982 in press.

38.

Hachisu

Nakamura

Kawashima

Shitoh

. “Re-lationship between enhancement of morphine analgesia and inhibition of enkephalin-ase by 2S, 3R 3-amino-2-hydroxy-4-phenyibutanoic acid derivatives”. Life Sci. 30: 1739–1746, 1982.

39.

Graf

Miglecz

Bajusz

and Szekely

“Met-enkephalin attenuates morphine tolerance in rats”. Eur. J. Pharm. 58: 345–346, 1979.

40.

C.Y.

Lin

C.S.

Peng

Cheng

C.S.

. “Suppression of morphine abstinence in heroin addicts by B-endrophin”. Adv. Biochem. Psychopharm. 22: 503–509, 1980.

41.

Takahashi

Izumi

Kaneto

and Koida

“Effects of psycho-tropic drugs in the levels of enkephalins, their receptors and enkephalinase of rat brain”, in Advances in Endogenous and Exogenous Opioids”, H. Takagi and E.J. Simon (eds.), Kodansha-EIsevier, Tokyo, 1982 in press.

42.

Malfroy

Swerts

J.P.

Buyon

Roques

B.P.

and Schwartz

J.S

. “High-affinity enkephalin-degrading peptidase in brain is increased after morphine”. Nature 276:523–526, 1978.

43.

Przewlocki

Hollt

Duka

Kleber

Gramsch

Haarmann

and Hertz

“Long-term morphine treatment decreases endorphin levels in rat brain and pituitary”. Brain Res. 174: 357–361, 1979-

44.

Hollt

Haarmann

Przewlocki

and Jerlicz

“Long-term treatment of rats with morphine decreases in vitro biosynthesis in and release of B-endorphin from intermediate/posterior lobes of pituitary”. Adv. Biochem. Psychopharm. 22: 399–407, 1980.

45.

Opmeer

Loeber

van Ree

J.M.

“Altered levels of B-endorphin fragments after chronic morphine treatment of guinea-pig ileum in vitro and in vivo”. Life Sci. 27: 2393–2400, 1980.

46.

Tortella

Cowan

and Adler

“D-ALA2-methionine enkephalin-amide and morphine are anticonvulsant after central administration in rats”. Soc. Neurosci. Abstr., Nov., 1979.

47.

Beckmann, Von H. and Ludolph, E. “DL-phenylalanin als antidrepressivum”. Arzneim.-Forsch. 28: 1283–1284, 1978.

48.

Fischer

Heller

Nachon

and Spatz

“Therapy of de-pression by phenylalanine”. Arzneim.-Forsch. 24 (1) 132, 1975.

49.

Heller

Fischer

and Martin

“Therapeutic action of 0- phenylalanine in parkinson's disease”. Arzneim.-Forsch. 26 (4) 577–579, 1976.

50.

Ferreira

and Nakamura

“Prostaglandin hyperalgesia: the peripheral analgesic activity of morphine, enkephalins and opioid antagonists”. Prostaglandins 18: 191–200, 1979.

51.

Ehrenpreis

Greenberg

and Belman

“Prostaglandins reverse inhibition of electrically-induced contractions of guinea pig ileum by morphine, indomethacin and acetylsalicylic acid”. Nature 245: 280–282, 1973-

52.

Kline

N.S.

C.H.

Lehman

H.D.

Lajtha

Laski

and Cooper

“B-endorphin-induced changes in schizophrenic and depressed patients”. Arch. Gen. Psychiat. 34: 11–1-1113, 1977.

53.

Gunne

L-H.

Lindstrom

and Widerlov

“Possible role of en- dophins in schizophrenia and other psychiatric disorders”, in Endorphins in Mental Health Research, E. Usdin, W. Bunney, Jr., and N. Kline (eds.), Oxford University Press, N.Y., 1979, PP. 547–56O.

54.

Omura

“Editorial: Pain threshold measurement before and after acupuncture: controversial results of radiant heat method and electrical method, and the roles of ACTH-like substances and endorphins,” Acupuncture & Electro-Therapeut. Res., Int. J., Vol. 3, pp. 1–21, 1978.

55.

Omura

“Acupuncture and ‘Transcutaneous Nerve Stimulation,” Section 7, Chapter 8, Management of Pain, pp. 360–382, in Pain: Its Basic Research and Treatment, H. Yamamura , eds., Asakura Publishing Co., Tokyo, 1st ed., 1980 & 2nd ed., 1981 (published in Japanese).

56.

Berger

P.P

. “Role of endorphins in schizophrenia: Clinical studies,” in Advances in Endogenous and Exogenous Opioids, H. Takagi and E.J. Simon (eds.), Kodansha-Elsevier, Tokyo, Japan, 1982 (in press).

57.

Davis

Bunney

Jr. , Buchsbaum

, Defraites

, Duncan

, Gillin

, van Kammen

, Kleinman

, Murphy

, Post

, Reus

and Wyatt

“Use of narcotic antagonists to study the role of endorphins in normal and psychiatric patients,” in Endorphins in Mental Health Research, Udin

E. E.

, Bunney

Jr. , and Kline

(eds.), Oxford University Press, N.Y., 1979, pp. 393–406.